EP3661494
USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTS
:
EP einkaleyfi: Þýðing ekki lögð inn:
2.8.2018:
11.10.2023:
18755664.2
:
1.8.2038
:
USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTS
2.8.2018
11.10.2023
:
Vanda Pharmaceuticals Inc.:
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, US
:
Polymeropoulos, Mihael:
10627 River's Bend Lane, Potomac, MD 20854, US
:
Polymeropoulos, Christos:
10627 River's Bend Lane, Potomac, MD 20854, US
:
Xiao, Changfu:
1235 Providence Terrace, McLean, VA 22101, US
:
POLYMEROPOULOS, Mihael:
Vienna VA 22182, US
:
POLYMEROPOULOS, Christos:
Vienna VA 22182, US
:
XIAO, Changfu:
McLean, VA 22101, US
:
201762540200 P:
2.8.2017:
US
:
US2018044995:
2.8.2018
:
A61K 31/343, A61K 45/06, A61P 25/24